Wyeth

Headquarters location: Five Giralda Farms Madison, NJ 07940 Tel. 973-660-5000 Job offers, investor relations: www.ahp.com Stock:

Wyeth belongs to shareholder country     % source AXA 2.2 Barclays Plc 5.2 FMR Corp. (Fidelity Investments) 5 JP Morgan & Co. 1.5 Mellon Financial Corp. 1.8 Morgan Stanley 1.7 Putnam LLC 1.7 State Street Corp. 2.7 Vanguard Group Inc. 1.9 Wellington Management Co. 2.2 Wyeth owns subsidiary country     % source Cyanamid 100 Fort Dodge 100 Genetics Institute 100 Whitehall Robins 100 Wyeth-Ayerst 100	Brands name items photo compare the prices Acel-Imune Ethishop Acrobat Ethishop Advil Ethishop AHP Ethishop Alesse Ethishop Amdro Ethishop American Home Products Ethishop Anacin Ethishop Anbesol Ethishop Arsenal Ethishop Assert Ethishop Ativan Ethishop Axid AR Ethishop Aygestin Ethishop Benefix Ethishop Bicillin Ethishop Cadre Ethishop Caltrate Ethishop Cardene Ethishop Centrum Ethishop Chap Stick Ethishop Chap Stick Ethishop Cordarone Ethishop Counter Ethishop CRINONE Ethishop Cycrin Ethishop Denorex Ethishop Detail Ethishop Diamox Ethishop Diazepam Ethishop Dimetapp Ethishop Dristan Ethishop Effexor Ethishop Enbrel Ethishop FiberCon Ethishop FluShield Ethishop HibTITER Ethishop Indera Ethishop Infumorph Ethishop ISMO Ethishop Isordil Ethishop Leukine Ethishop Lightning Ethishop Lo/Ovral Ethishop Lodine Ethishop Mepergan Ethishop Micro-K Ethishop Minocin Ethishop Modilac Ethishop Myambutol Ethishop Naprelan Ethishop Neumega Ethishop Nordette Ethishop Normiflo Ethishop Novantrone Ethishop Orimune Ethishop Orudis Ethishop Orudis KT Ethishop Oruvail Ethishop Ovral Ethishop Ovrette Ethishop Phenergan Ethishop Pipracil Ethishop Pnu-Imune Ethishop Pondimini Ethishop Premarin Ethishop Premphase Ethishop Prempro Ethishop Preparation H Ethishop Primatene Ethishop Prowl Ethishop Pursuit Ethishop Quinidex Ethishop Redux Ethishop Reglan Ethishop Resolve Ethishop Robitussin Ethishop Rotashield Ethishop Scepter Ethishop Sectral Ethishop Serax Ethishop SMA Ethishop SMA Ethishop Sodilac Ethishop Solgar Ethishop Squadron Ethishop Steel Ethishop Stuartnatal Plus Ethishop Suprax Ethishop Synvisc Ethishop Tenex Ethishop Tetramune Ethishop Thimet Ethishop Thioplex Ethishop Tri-Immunol Ethishop Triphasil Ethishop Tubex Ethishop Verelan Ethishop Wydase Ethishop Wyeth Ethishop Zebeta Ethishop Ziac Ethishop Zosyn Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF WYETH , group and subsidiaries [?] 9% Job: 9% of company's jobs cut since 1998 1 Environment: 1 major pollution(s) 2 Delinquency: 2 act(s) of financial or trade delinquency 3 Tax haven, secret bank account, shell companies: operates in 3 offshore financial center(s) 15 Sales: more than 15 billion(s) dollars/euros in annual sales 7 Net profit: more than 7 billion(s) dollars/euros in cumulated net profit since 1998 666 Top management: earns 666 times the median income in the United States (32000 US$/year) 9 Influence: 9 act(s) of direct corruption or lobbying 1 Advertising & marketing: 1 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2006 Wyeth is the world's eleventh-largest pharmaceutical group. Les Echos 2006 Wyeth sells 16% of the vaccines bought in the world. Les Echos World locations & Manufacturing country incentive : address & contact : production type source Newbridge : R&D Les Echos Limerick : R&D Les Echos AHP Finance Ireland Ltd., Dublin : Dimminaco AG : The map of tax haven, secret accounts and shell companies Wyeth is managed by year name photo position; compensation source 2002Essner, Robert Chief Executive Officer; salary: 3.13 million US$; stock-options: 3.64 million US$; 2002Martin, Kenneth Chief Financial Officer; salary: 1.64 million US$; stock-options: 0.24 million US$; 1999Alexander, Clifford L Director; 1999Bennack, Franck A Director; 1999Essner, Robert Director; 1999Feerick, John D Director; 1999Mascotte, John P Director; 1999Polan, Mary Lake Director; 1999Torell, John R Director; 1999Van G Seidenberg, I Director; 1998Stafford, John R Chief Executive Officer; salary: 21.34 million US$; Forbes Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2007 Disinformation: In early September, "major newspapers reported the alarming news that suicides among young people were on the rise because of a precipitous drop in the use of antidepressants," writes Alison Bass. The academic study the news articles were based on concluded that new safety warnings for young people using antidepressant drugs had discouraged doctors from writing prescriptions for depressed youths. But there's a hole in that argument: "while there was indeed an upturn in suicide rates among youths ... the number of prescriptions for antidepressants in the same age group remained basically unchanged." Bass points out that the pharmaceutical companies that make antidepressants might "benefit from the latest alarm about an apparent upturn in youth suicide rates. ... These companies have an enormous stake in reversing the current FDA warnings." Pfizer, which makes the antidepressant Zoloft, did provide $30,000 for the academic study, and the study's lead authors have ties to Pfizer, GlaxoSmithKline and Wyeth Pharmaceuticals. "This isn't the first time that suicide rates have been trotted out as a public relations weapon," Bass adds. "Proponents of psychotropic drugs have long argued that suicide rates ... fell after" such drugs were introduced, though the decline began well before the drugs were widely prescribed.: Boston Glo. 2001 ad budget: 400 million US$; Advertisin. 2000 ad budget: 445 million US$; Advertisin. 1998 ad budget: 428 million US$; Advertisin. 1997 ad budget: 443 million US$; Advertisin. Dubious practices in 2007

Made by year employees <> social impact : country source 2008 50000 -5000 Internal restructuring: Wyeth told managers about 10 percent of its 50,000 employees worldwide might lose their jobs by 2011 under a sweeping reorganization dubbed "Project Impact.": United States of America AP 2005 -1200 Closure/Bankruptcy: United States of America Les Echos 2002 52762 2001 52289 2000 48036 1999 -3000 AP 1999 -700 Reuters 1998 60523 Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2007 United States of America : Wyeth was condemned to pay 134 million dollars to three patients who developed a breast cancer because of their hormonal treatment Premanal and Prempro. Les Echos 2005 United States of America : Wyeth a versé 14 milliards de dollars aux patients qui ont pris son coupe-faim Redux, retiré du marché en 1997. Wyeth a provisionné 7 milliards de plus pour les paiements futurs. Les Echos Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2001 Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translate USCIB 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 2000 Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translate Center for. 1998 Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 52 thousand US$ : US President, Congress, Senate translate Center for. 1997 Legislation favorable to company's interests : Direct donation : amount: 103 thousand US$ : US President, Congress, Senate translate Center for. 1997 Legislation favorable to company's interests : Direct donation : amount: 2500 thousand US$ : US President, Congress, Senate translate Center for. Influence in 2007 Financials year financial misdemeanor sales income source 2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian P. 2004   1.23   billion US$ Les Echos 2002   14.58 4.45   billion US$ 2002 Pratiques fiscales douteuses, déclarations mensongères aux auditeurs, utilisation frauduleuse des budgets marketing, inventaires gonflés, contrats avec des sociétés liées à certains dirigeants, primes déposées dans des comptes offshore…     New York T. 2001   14.13 2.29   billion US$ 2000   13.26 -2.37   billion US$ 1999   13.55 -1.23   billion US$ 1998   13.46 2.47   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email